The inhibition of S100A9 with drugs and inhibitors markedly attenuates brain injury after subarachnoid hemorrhage [81], reduces mortality rates in murine models of sepsis [82] and traumatic brain injury [83], and improves the viability and survival rate of neurons after spinal cord injury [84]. The gene discussed is S100A9; the disease is Sepsis.